Table 3 Cox regression analyses: p53 mutation status in p53 mutant breast cancer patients expressing p53γ is not associated with death and cancer recurrence

a

1

Tumour grade 3

2.12

0.005

8.33 (1.90 to 36.47)

1

PR

-0.99

0.021

0.37 (0.16 to 0.86)

b

2

PR

-1.36

0.011

0.26 (0.09 to 0.74)

1

p53m

1.06

0.012

2.87 (1.27 to 6.51)

c

2

p53m

1.1

0.026

3.00 (1.14 to 7.85)

2

Tumour grade 3

1.51

0.003

4.52 (1.60 to 12.11)

d

3

ER

-1.54

0.002

0.21 (0.08 to 0.55)

3

HER2

1.16

0.012

3.18 (1.29 to 7.83)

e

4

HER2

1.21

0.026

3.35 (1.16 to 9.65)

4

ER

-1.05

0.012

0.35 (0.16 to 0.79)

f

5^b

Lymph nodes

1.19

0.037

3.30 (1.08 to 10.13)

5^b

Lymph nodes

0.93

0.039

2.53 (1.05 to 6.09)

g

6^b

p53β

-0.38

0.491

0.69 (0.24 to 2.00)

6^b

p53β

-0.17

0.699

0.84 (0.35 to 2.03)

h

6^b

p53γ

0.48

0.337

1.61 (0.61 to 4.29)

6^b

p53γ

0.19

0.652

1.21 (0.52 to 2.81)

i

5^b

p53m&p53β⁺

0.07

0.451

1.47 (0.54 to 3.99)

5^b

p53m&p53β⁺

0.97

0.053

2.65 (0.99 to 7.10)

j

5^b

p53m&p53γ⁺

0.31

0.626

1.36 (0.39 to 4.75)

5^b

p53m&p53γ⁺

0.49

0.333

1.63 (0.61 to 4.36)

k

2

p53m&p53β⁺ p53γ^-

2.87

0.017

17.56 (1.66 to 186.15)

4

p53m&p53β⁺&p53γ^-

1.71

0.021

5.51 (1.29 to 23.57)

l

5^b

p53m&p53γ⁺&p53β^-

0.78

0.298

2.19 (0.50 to 9.59)

5^b

p53m&p53γ⁺&p53β^-

0.31

0.679

1.36 (0.32 to 5.78)